FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899335021> ?p ?o ?g. }

• W2899335021 endingPage "e0206786" @default.
• W2899335021 startingPage "e0206786" @default.
• W2899335021 abstract "Neural cell adhesion molecule (NCAM) and fibroblast growth factor receptor 1 (FGFR1) cross-talk have been involved in epithelial-to-mesenchymal transition (EMT) process during carcinogenesis. Since EMT also contributes to maladaptive repair and parenchymal damage during renal fibrosis, we became encouraged to explore the role of NCAM/FGFR1 signaling as initiating or driving forces of EMT program in cultured human proximal tubular epithelial cells (TECs). TECs stimulated with TGF-β1 (10ng/mL) was used as an established in vitro EMT model. TGF-β1 downstream effectors were detected in vitro, as well as in 50 biopsies of different human kidney diseases to explore their in vivo correlation. NCAM/FGFR1 signaling and its modulation by FGFR1 inhibitor PD173074 (100nM) were analyzed by light microscopy, immunolabeling, qRT-PCR and scratch assays. Morphological changes associated with EMT appeared 48h after TGF-ß1 treatment and was clearly apparent after 72 hours, followed by loss of CDH1 (encoding E-Cadherin) and transcriptional induction of SNAI1 (SNAIL), SNAI2 (SLUG), TWIST1, MMP2, MMP9, CDH2 (N-Cadherin), ITGA5 (integrin-α5), ITGB1 (integrin-β1), ACTA2 (α-SMA) and S100A4 (FSP1). Moreover, at the early stage of EMT program (24 hours upon TGF-β1 exposure), transcriptional induction of several NCAM isoforms along with FGFR1 was observed, implicating a mechanistic link between NCAM/FGFR1 signaling and induction of EMT. These assumptions were further supported by the inhibition of the EMT program after specific blocking of FGFR1 signaling by PD173074. Finally, there was evidence for an in vivo TGF-β1 pathway activation in diseased human kidneys and correlation with impaired renal excretory functions. Collectively, NCAM/FGFR1 signaling appears to be involved in the initial phase of TGF-ß1 initiated EMT which can be effectively suppressed by application of FGFR inhibitor." @default.
• W2899335021 created "2018-11-09" @default.
• W2899335021 creator A5006754785 @default.
• W2899335021 creator A5025662877 @default.
• W2899335021 creator A5032260421 @default.
• W2899335021 creator A5033956571 @default.
• W2899335021 creator A5041974767 @default.
• W2899335021 creator A5056684667 @default.
• W2899335021 creator A5057980983 @default.
• W2899335021 creator A5059964027 @default.
• W2899335021 creator A5068060318 @default.
• W2899335021 date "2018-11-01" @default.
• W2899335021 modified "2023-10-15" @default.
• W2899335021 title "Modulation of NCAM/FGFR1 signaling suppresses EMT program in human proximal tubular epithelial cells" @default.
• W2899335021 cites W1510884166 @default.
• W2899335021 cites W1760215417 @default.
• W2899335021 cites W1894355534 @default.
• W2899335021 cites W1905813498 @default.
• W2899335021 cites W1969109536 @default.
• W2899335021 cites W1976342995 @default.
• W2899335021 cites W1986943933 @default.
• W2899335021 cites W1993345123 @default.
• W2899335021 cites W2022258892 @default.
• W2899335021 cites W2022409734 @default.
• W2899335021 cites W2028879735 @default.
• W2899335021 cites W2032810306 @default.
• W2899335021 cites W2046692530 @default.
• W2899335021 cites W2053247155 @default.
• W2899335021 cites W2071467611 @default.
• W2899335021 cites W2075274680 @default.
• W2899335021 cites W2080236355 @default.
• W2899335021 cites W2080786809 @default.
• W2899335021 cites W2094262584 @default.
• W2899335021 cites W2099297320 @default.
• W2899335021 cites W2100013882 @default.
• W2899335021 cites W2103572856 @default.
• W2899335021 cites W2108579114 @default.
• W2899335021 cites W2110886621 @default.
• W2899335021 cites W2110962672 @default.
• W2899335021 cites W2124192032 @default.
• W2899335021 cites W2129666547 @default.
• W2899335021 cites W2132394486 @default.
• W2899335021 cites W2137898353 @default.
• W2899335021 cites W2145497113 @default.
• W2899335021 cites W2156808480 @default.
• W2899335021 cites W2156935689 @default.
• W2899335021 cites W2162900557 @default.
• W2899335021 cites W2169281671 @default.
• W2899335021 cites W2189664213 @default.
• W2899335021 cites W2611502890 @default.
• W2899335021 cites W2612909210 @default.
• W2899335021 doi "https://doi.org/10.1371/journal.pone.0206786" @default.
• W2899335021 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6211750" @default.
• W2899335021 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30383875" @default.
• W2899335021 hasPublicationYear "2018" @default.
• W2899335021 type Work @default.
• W2899335021 sameAs 2899335021 @default.
• W2899335021 citedByCount "12" @default.
• W2899335021 countsByYear W28993350212019 @default.
• W2899335021 countsByYear W28993350212020 @default.
• W2899335021 countsByYear W28993350212021 @default.
• W2899335021 countsByYear W28993350212022 @default.
• W2899335021 countsByYear W28993350212023 @default.
• W2899335021 crossrefType "journal-article" @default.
• W2899335021 hasAuthorship W2899335021A5006754785 @default.
• W2899335021 hasAuthorship W2899335021A5025662877 @default.
• W2899335021 hasAuthorship W2899335021A5032260421 @default.
• W2899335021 hasAuthorship W2899335021A5033956571 @default.
• W2899335021 hasAuthorship W2899335021A5041974767 @default.
• W2899335021 hasAuthorship W2899335021A5056684667 @default.
• W2899335021 hasAuthorship W2899335021A5057980983 @default.
• W2899335021 hasAuthorship W2899335021A5059964027 @default.
• W2899335021 hasAuthorship W2899335021A5068060318 @default.
• W2899335021 hasBestOaLocation W28993350211 @default.
• W2899335021 hasConcept C104317684 @default.
• W2899335021 hasConcept C122871604 @default.
• W2899335021 hasConcept C127561419 @default.
• W2899335021 hasConcept C1491633281 @default.
• W2899335021 hasConcept C170493617 @default.
• W2899335021 hasConcept C2776364838 @default.
• W2899335021 hasConcept C49418065 @default.
• W2899335021 hasConcept C502942594 @default.
• W2899335021 hasConcept C54355233 @default.
• W2899335021 hasConcept C74373430 @default.
• W2899335021 hasConcept C76419328 @default.
• W2899335021 hasConcept C82867764 @default.
• W2899335021 hasConcept C85789140 @default.
• W2899335021 hasConcept C86803240 @default.
• W2899335021 hasConcept C95444343 @default.
• W2899335021 hasConceptScore W2899335021C104317684 @default.
• W2899335021 hasConceptScore W2899335021C122871604 @default.
• W2899335021 hasConceptScore W2899335021C127561419 @default.
• W2899335021 hasConceptScore W2899335021C1491633281 @default.
• W2899335021 hasConceptScore W2899335021C170493617 @default.
• W2899335021 hasConceptScore W2899335021C2776364838 @default.
• W2899335021 hasConceptScore W2899335021C49418065 @default.
• W2899335021 hasConceptScore W2899335021C502942594 @default.
• W2899335021 hasConceptScore W2899335021C54355233 @default.

• next